Synlab highlights the value of genetic counseling in breast cancer prevention in October.

October is globally recognized as Breast Cancer Awareness Month, a key time to promote early detection and prevention of this disease. In line with these goals, SYNLAB has focused on reinforcing the importance of genetic counseling, presenting it as an invaluable tool that helps people make informed decisions about their health.

Genetic counseling is especially vital for those with a family history of cancer. Through this guidance, individuals can better understand their hereditary risk and, together with their doctors, determine the most appropriate preventive strategies. These strategies can range from increased medical surveillance to the adoption of personalized prevention measures.

Dr. Carlos Iván Rivera, Clinical Genetic Specialist at SYNLAB, emphasizes: “Each person has a unique story, including their genetic background. Understanding these factors is essential for making decisions that can save lives.” According to him, SYNLAB’s goal is not only to provide technical information, but also to offer support and clarity to guide people on how to act on these results and how to effectively prevent breast cancer.

During Breast Cancer Awareness Month, the company emphasizes not only the importance of mammograms and regular check-ups, but also the value of knowing one’s personal genetics and acting proactively. While many cases of breast cancer are not hereditary, a significant number are, making genetic testing essential in the fight against this disease.

An example of this is SYNLAB’s BRCA+16 Genes test, which evaluates 18 genes related to the hereditary risk of cancer, including the well-known BRCA1 and BRCA2, which are linked to a considerable number of cases of hereditary breast and ovarian cancer. This test not only focuses on gynecological cancer, but also explores genes associated with hereditary prostate, melanoma, pancreatic, and colon cancers, providing a comprehensive view.

The results of these tests offer crucial data for individuals with personal and family history of cancer. However, interpreting this information can be complex and sometimes cause anxiety if the proper context is not provided. For this reason, SYNLAB provides genetic counseling not only to the patient, but also to their relatives and the requesting physician.

Dr. Carlos Iván Rivera emphasizes: “It is crucial that we integrate the genetic approach into the conversation about breast cancer. At SYNLAB, we focus not only on the test results, but on how people can use that information to live more calmly and healthily. Support is essential.”

Beyond breast cancer awareness, this month highlights the importance of taking a broader approach to prevention. Genetic knowledge allows for the identification of risks not only for breast cancer, but also for other types such as ovarian, prostate, colorectal, and pancreatic cancer, allowing for a more comprehensive and personalized prevention.

SYNLAB’s genetic counseling offers personalized support, allowing patients to understand their genetic profile and make evidence-based decisions. It is not just about providing a diagnosis, but a comprehensive approach that combines genetic information with the necessary professional support to make informed decisions.

Source: MiMub in Spanish

Scroll to Top